Impact of SGLT2 inhibitors on functional outcomes in heart failure patients according to the aetiology
SGLT2i improved exercise capacity only in non-ischemic HFrEF patients, suggesting a differential response based on etiology.
Authors
- Eva González Caballero
- Sergio Gamaza‐Chulián (ORCID: https://orcid.org/0000-0003-2454-155X)
- José Adriano Ferreira Silva (ORCID: https://orcid.org/0000-0002-0008-9338)
- Alberto Giráldez Valpuesta
- Eleonora Coppo
- Juan Rebollo (ORCID: https://orcid.org/0000-0003-2902-2353)
Institutions
- Hospital Jerez Puerta del Sur (ES)
Publication Details
- Journal
- Expert Review of Cardiovascular Therapy
- Published
- 2025-07-14
- DOI
- https://doi.org/10.1080/14779072.2025.2534712
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boehringer Ingelheim